MedPath

Study to compare the effect of two blocks namely shoulder block and interscalene block in providing pain relief post surgery in patients undergoing arthroscopic shoulder surgery.

Not Applicable
Conditions
Health Condition 1: null- adults undergoing elective shoulder surgery
Registration Number
CTRI/2018/03/012680
Lead Sponsor
Vardhman Mahavir Medical College and Safdarjung Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Adult patients 18-60years of age of either sex scheduled to undergo elective unilateral arthroscopic shoulder surgery under ASA grades I and II.

Exclusion Criteria

a. History of allergy to local anaesthetic and contraindications to block (history of coagulopathy or on anticoagulants, local site infection)

b. BMI greater than 30 kg/m2 and inability to understand pain scale (Visual analogue scale).

c. Pulmonary, cardiac, hepatic, renal diseases and previous neurological deficit in the upper

limbs.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the efficacy, safety and duration of postoperative analgesia provided by shoulder block versus interscalene block using ultrasound and nerve stimulation as guidance in arthroscopic shoulder surgery.Timepoint: Postoperative pain will be evaluated at 0, 2, 4, 6, 12 and at 24 hours from the completion of surgery using VAS scoring from zero (no pain) to 10 (worst pain). .
Secondary Outcome Measures
NameTimeMethod
â?¢To compare the total amount of rescue analgesia required in each group. <br/ ><br>â?¢To compare patient satisfaction in terms of quality of pain relief using Visual analogue scale (VAS) in relation to both the techniques. <br/ ><br>Timepoint: Time of first rescue analgesia will be noted and total amount of analgesia required will also be noted. <br/ ><br>Patient satisfaction will be assessed in terms of quality of pain relief using visual analogue scale (VAS: 0-10) at the end of 24 hours. <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath